p resented by Jan Haas Institute for Immunology

12
presented by Jan Haas Institute for Immunology

description

p resented by Jan Haas Institute for Immunology. Influenzaviruses: Orthomyxoviridae. 16 Haemagglutinin 9 Neuraminidase - types 3 Polymerase Subunits Nucleoprotein Nuclear Export Protein (NEP) Matrix Protein (M1) Ion Channel Protein (M2) Interferon Antagonist (NS1) PB1-F2 Protein. - PowerPoint PPT Presentation

Transcript of p resented by Jan Haas Institute for Immunology

Page 1: p resented by Jan Haas Institute for Immunology

presented by Jan Haas

Institute for Immunology

Page 2: p resented by Jan Haas Institute for Immunology

Influenzaviruses: Orthomyxoviridae16 Haemagglutinin9 Neuraminidase- types

3 Polymerase Subunits

Nucleoprotein

Nuclear Export Protein (NEP)

Matrix Protein (M1)

Ion Channel Protein (M2)

Interferon Antagonist (NS1)

PB1-F2 Protein

Page 3: p resented by Jan Haas Institute for Immunology

The viral life cycle

o(-) RNA virusoenvelopedoInfluenza A responsible for pandemic outbreaksospread via aerosols and droplets

Page 4: p resented by Jan Haas Institute for Immunology

Historical overview

Page 5: p resented by Jan Haas Institute for Immunology

Genetic Relationships among Human and Relevant Swine Influenza Viruses, 1918–2009.Yellow arrows reflect exportation of one or more genes from the avian influenza A virus gene pool. The dashed red arrow indicates a period without circulation. Solid red arrows indicate the evolutionary paths of human influenza virus lineages; solid blue arrows, of swine influenza virus lineages; and the blue-to-red arrow, of a swine-origin human influenza virus. All influenza A viruses contain eight genes that encode the following proteins (shown from top to bottom within each virus): polymerase PB2, polymerase PB1, polymerase PA, hemagglutinin (HA), nuclear protein (NP), neuraminidase (NA), matrix proteins (M), and nonstructural proteins (NS). The genes of the 1918 human and swine H1N1 and the 1979 H1N1 influenza A viruses were all recently descended from avian influenza A genes, and some have been “donated” to the pandemic human H1N1 strain.

‘H5N1’ influenza (1997-2003)oHong Kong: highly pathogenic avian virusosix fatalities, marked the first reported fatal infections of humans with avian influenza viruses oafter a period of local and sporadic outbreaks, a new outbreak started in 2003osustained human-to-human infection has not occurredoH5N1 viruses are characterized by a high mortality rate but inefficient spread among humans

in contrast, S-OIVs seem to spread efficiently among humans but have caused a limited number of fatal infections

‘Russian’ influenza (H1N1, 1977)othe re-emerging H1N1 virus did not replace the H3N2 viruses circulating at the timeoboth subtypes are co-circulating in humans to this dayoreassortment between viruses of these subtypes resulted in the emergence of H1N2 viruses in human populations in 2001oH1N2 viruses have since disappeared.

‘Asian’ influenza (H2N2, 1957-1958)owas caused by a human/avian reassortant that introduced avian virus H2 HA and N2 NA genes into human populations

ofurthermore, the Asian influenza virus also possessed a PB1 gene of avian virus origin

‘Hongkong’ influenza (H3N2, 1968-1970)oviruses of the H2N2 subtype were replaced by another human/avian reassortant that possessed an H3 HA gene of avian virus origin

oagain, the PB1 gene of the pandemic virus was derived from an avian virus‘S-OIV H1N1’ influenza (2009)

oS-OIVs probably resulted from the reassortment of recent North American H3N2 and H1N2 swine viruses (that is, avian/human/swine ‘triple’ reassortant viruses) with Eurasian avian-like swine virusesoS-OIVs possess: PB2 and PA genes of North American avian virus origin, a PB1 gene of human H3N2 virus origin, HA (H1), NP, and NS genes of classical swine virus origin, and NA (N1) and M genes of Eurasian avian-like swine virus origin (hence their original description as ‘quadruple’ reassortants)

‘Spanish’ influenza (H1N1, 1918-1919)o mortality pattern unusual: young adultsorestricted to the respiratory tract, lack of systemic infectionomost patients died of bacterial pneumonia, some as well of viral pneumoniaoaberrant innate immune responses contributing to its virulence

Page 6: p resented by Jan Haas Institute for Immunology

Genesis of swine-origin H1N1 influenza viruses

‘mixing vessel’

Page 7: p resented by Jan Haas Institute for Immunology

Electron microscopic picture: H1N1

Page 8: p resented by Jan Haas Institute for Immunology

Role of HA in viral pathogenicityReceptor distribution on host cells: ohuman influenza preferentially bind to sialic acid that is linked to galactose by an 2,6-linkage (SA2,6Gal)othis preference is matched by SA2,6Gal on epithelial cells in the human tracheaoin contrast, avian influenza viruses preferentially recognize SA2,3Gal that is matched by SA2,3Gal on epithelial cells in the intestinal tract of waterfowl (the main replication site of avian influenza viruses)osurprisingly H5N1 binds preferentially to SA2,3Galostudies showed avian-type receptors (SA2,3Gal) on human epithelial cells that line the respiratory bronchiole and the alveolar walls, but human-type receptors (SA2,6Gal) on human epithelial cells in nasal mucosa, paranasal sinuses, pharynx, trachea and bronchiHA receptor specificity: amino acid residues in the HA receptor binding pocket determine binding to human/avian type receptors

HA cleavage: HA cleavability determined by the amino acid sequence at the cleavage siteoLow pathogenic viruses possess a Arg residue at the cleavage siteohighly pathogenic H5 and H7 viruses possess several basic amino acids at the HA cleavage site pathogenicity correlates with acquisition of multibasic HA cleavage sites

Page 9: p resented by Jan Haas Institute for Immunology

Role of PB2, NS1 and PB1-F2 in pathogeniciy and host specificity

PB2: belongs to the viral replication complexPB1-F2: is expressed from the +1 reading frame, induces apoptosis by interaction with two mitochondrial proteinsNS1: the NS1 protein is an interferon antagonist that blocks the activation of transcription factors and IFN--stimulated gene products, and binds to double-stranded RNA (dsRNA) to prevent the dsRNA-dependent activation of 2’-5’ oligo(A) synthetase, and the subsequent activation of RNase L; can block RIG-I, MDA5 and TLR-3,7 & 8

Page 10: p resented by Jan Haas Institute for Immunology

Prevention and control

Antiviral drugs:

M1: AdamantanesNA: Oseltamivir (Tamiflu) and Zanamivir, PeramivirCS-8958 (NA) Phase IIT-705 (Nucleoside analogue) Phase IIImAb against HA

Vaccines: produced in allantoid fluid of embryonated chicken/cell culture

Pandemrix (GSK) (dead vaccine)Focetria (Novartis) (dead vaccine)Celvapan (Baxter) (cell culture)Celtura (Behring) (cell culture)

Live attenuated viruses yield higher humoral and cellular immune responses

Page 11: p resented by Jan Haas Institute for Immunology

Thank you for your attention!

Page 12: p resented by Jan Haas Institute for Immunology

“History” of the virus